BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4325624)

  • 1. Purification and some properties of kappa toxin of Clostridium perfringens.
    Kameyama S; Akama K
    Jpn J Med Sci Biol; 1971 Feb; 24(1):9-23. PubMed ID: 4325624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure and function of Cl. perfringens toxin].
    Ispolatovskaia MV
    Vestn Akad Med Nauk SSSR; 1973; 28(11):83-9. PubMed ID: 4132138
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
    Mitsu K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Apr; 43(2):65-80. PubMed ID: 4352113
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens.
    Möllby R; Nord CE; Wadström T
    Toxicon; 1973 Feb; 11(2):139-47. PubMed ID: 4351816
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.
    Smyth CJ; Arbuthnott JP
    J Med Microbiol; 1974 Feb; 7(1):41-66. PubMed ID: 4369079
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification of Clostridium perfringens type C theta toxin.
    Hauschild AH; Lecroisey A; Alouf JE
    Can J Microbiol; 1973 Aug; 19(8):881-5. PubMed ID: 4356555
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Möllby R; Wadström T
    Biochim Biophys Acta; 1973 Oct; 321(2):569-84. PubMed ID: 4357667
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Bird RA; Low MG; Stephen J
    FEBS Lett; 1974 Aug; 44(3):279-81. PubMed ID: 4370089
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification and some properties of Clostridium botulinum type-E toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochim Biophys Acta; 1968 Oct; 168(2):207-17. PubMed ID: 4972262
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 11. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 12. A STUDY OF THE SOLUBLE ANTIGENS OF CLOSTRIDIUM PERFRINGENS TYPE D.
    HABEEB AF
    Can J Microbiol; 1964 Apr; 10():287-98. PubMed ID: 14171648
    [No Abstract]   [Full Text] [Related]  

  • 13. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification of Clostridium perfringens phospholipase C (alpha-toxin) by affinity chromatography on agarose-linked egg-yolk lipoprotein.
    Takahashi T; Sugahara T; Ohsaka A
    Biochim Biophys Acta; 1974 May; 351(1):155-71. PubMed ID: 4365891
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha toxoid of Clostridium perfringens. I. Purification and toxoiding of alpha toxin of C. perfringens.
    Ito A
    Jpn J Med Sci Biol; 1968 Dec; 21(6):379-91. PubMed ID: 4306752
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation of the sixth component of complement from human serum.
    Arroyave CM; Müller-Eberhard HJ
    Immunochemistry; 1971 Nov; 8(11):995-1006. PubMed ID: 4110102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary data on the purification and structure of Clostridium perfringens alpha-toxin].
    Teodorescu G; Bittner J; Ceacăreanu A
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):541-4. PubMed ID: 4328576
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating tissue antigens. II. Studies on an organ-specific antigen of human liver.
    Espinosa E
    Lab Invest; 1973 Nov; 29(5):556-61. PubMed ID: 4201789
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and biochemical properties of Clostridium perfringens type A enterotoxin.
    Stark RL; Duncan CL
    Infect Immun; 1972 Nov; 6(5):662-73. PubMed ID: 4344364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A partial characterization of the alpha-toxin of Clostridium oedematiens type B.
    Phillips AW; Batty I; Wood RD
    Eur J Biochem; 1970 Jun; 14(2):367-71. PubMed ID: 4990160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.